XML 24 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 8 - Derivative Financial Instruments
9 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Derivative Instruments and Hedging Activities Disclosure [Text Block]
NOTE
8
-
Derivative Financial Instruments
 
In
September 2017
the Company began originating and selling mortgage loans under mandatory delivery sales commitments in an effort to realize greater sales gains and
entering into fixed-rate MBS forward commitments to mitigate the resulting pipeline interest rate risk. Although the MBS forward sales commitments serve as financial interest rate hedges, the Company does
not
designate any of its derivative financial instruments as hedges for accounting purposes.
O
utstanding derivative financial instrument assets at
September 30, 2017
include
$235,000
in interest rate lock commitments and
$21,000
in derivative hedge instruments. Net gains recognized by the Company on its derivative financial instruments, which are included in "Gain on sale of loans" on its consolidated statements of operations for the
three
and
nine
months ended
September 30, 2017
were
$
260,000
,
including
$
235,000
from interest rate lock commitments and
$
24,000
from MBS forward trades. 
The notional amount of open MBS forward trades at
September 30, 2017
was
$12.2
million.
 
The Company has exposure to credit loss in the event of contractual non-performance by its trading counterparties and counterparties to the over-the-counter derivative financial instruments that the Company uses in its interest rate risk management activities. The Company manages this credit risk by selecting only
top-tier national investment firms the Company believes to be financially strong, spreading the credit risk among at least
three
such broker/dealer counterparties and by entering into netting agreements with the counterparties, as appropriate.
The Company has entered into agreements with
three
derivative counterparties, a portion of which include netting arrangements whereby the counterparties are entitled to settle their positions on a net basis. However, with respect to this portion of its derivatives, the Company presents such amounts on a gross basis in its financial statements. In certain circumstances, the Company
may
be required to provide certain derivative counterparties collateral against derivative financial instruments. As of
September 30, 2017,
these
counterparties did
not
hold any of the Company’s cash or cash equivalents in margin accounts as collateral (which would be classified as "Restricted cash" on the Company's consolidated balance sheets). The Company was in a
$24,000
net credit/gain position to those counterparties at
September 30, 2017.
The Company has never incurred credit losses due to non-performance of its counterparties.